Work

Survival outcomes of Black/African American (B/AA) patients with HER2-negative (IHC 0, 1+, 2+ and ISH-), advanced breast cancer (HER2-neg aBC) across three academic cancer centers in the United States.

Year: 2024

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2024.20.10_suppl.129

Authors: Chia Jie Tan, Connor Willis, Trang Au, Matthew B. Schabath, Chenghui Li, Kristen Kelley, Xiaoqing Xu, Leah Park, Clara Lam, Sandhya Mehta, Jackie Kwong, Diana Brixner, David D. Stenehjem

Institutions: University of Utah, Moffitt Cancer Center, University of Arkansas for Medical Sciences, Huntsman Cancer Institute, AstraZeneca (United States), Daiichi Sankyo (United States), University of Minnesota, University of Minnesota, Duluth

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4402987594

Cites:

Cited by:

Related to: 10